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Abstract
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Context—Although the prevalence of depression among medical interns substantially exceeds
that of the general population, the specific factors responsible are not well understood. Recent
reports of a moderating effect of a genetic polymorphism (5-HTTLPR) in the serotonin transporter
protein gene on the likelihood that life stress will precipitate depression may help to understand
the development of mood symptoms in medical interns.
Objective—To identify psychological, demographic and residency program factors that associate
with depression among interns and use medical internship as a model to study the moderating
effects of this polymorphism using a prospective, within-subject design that addresses the design
limitations of earlier studies.
Design—Prospective cohort study
Setting—13 United States hospitals
Participants—740 interns entering participating residency programs
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Main outcome measures—Subjects were assessed for depressive symptoms using the Patient
Health Questionnaire (PHQ-9), a series of psychological traits and 5-HTTLPR genotype prior to
internship and then assessed for depressive symptoms and potential stressors at 3-month intervals
during internship.
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Results—The PHQ-9 depression score increased from 2.4 prior to internship to a mean of 6.4
during internship (p<0.001). The proportion of participants who met PHQ-9 criteria for depression
increased from 3.9% prior to internship to a mean of 25.7% during internship (p<0.001). A series
of factors measured prior to internship (female sex, U.S. medical education, difficult early family
environment, history of major depression, lower baseline depressive symptom score and higher
neuroticism) and during internship (increased work hours, perceived medical errors and stressful
life events) were associated with a greater increase in depressive symptoms during internship. In
addition, subjects with at least one copy of a less transcribed 5-HTTLPR allele reported a greater
increase in depressive symptoms under the stress of internship (p=0.002).
Conclusions—There is a marked increase in depressive symptoms during medical internship.
Specific individual, internship and genetic factors are associated with the increase in depressive
symptoms.
Keywords
Graduate; Medical; Education; Residency; Serotonin; Transporter
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Internship is known to be a time of high stress1,2. New physicians are faced with long work
hours, sleep deprivation, loss of autonomy and extreme emotional situations3. A series of
cross sectional studies has examined the prevalence of significant depressive symptoms
among interns. Although the proportion of interns who screen positive for major depression
varied markedly across these studies (7%-49%), most studies found rates of major
depression among interns to be higher than the rates found in the general population
(4-5%)2,6-16.
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Prospective, longitudinal studies are necessary to understand the factors underlying the
development of depression among interns. Prospective studies of depression during
internship to date have yielded inconsistent findings; some studies reported that factors such
as female sex, neuroticism and medical errors were associated with increased depression,
but other studies failed to replicate these results14,17-24. A review of these studies concluded
that it is difficult to draw firm conclusions because each of the studies had significant
limitations25. Most notably, the studies enrolled relatively small samples that were restricted
to individual residency programs or institutions, and suffered from high attrition rates and
short follow-up periods25. Further many potentially important factors, such as work hours,
social support and negative life events, have not been well explored in internship depression.
We report here on the largest longitudinal study to date of a sample of interns drawn from
multiple institutions and specialties over a 14-month period, which aims to identify factors
associated with the development of depression during internship.
Genetic epidemiological studies indicate that in addition to life stressors, genetic factors play
a major role in the etiology of depression26. The gene most extensively investigated in
depression is SLC6A4, which encodes the serotonin transporter protein. The serotonin
transporter is a transmembrane protein located on the presynaptic membrane of serotonergic
neurons. It is a major target of many common antidepressant medications such as selective
serotonin reuptake inhibitors and tricyclic antidepressants.
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Caspi and colleagues27 reported an interaction between a functional promoter polymorphism
at this locus (5-HTTLPR) and life stress in the development of depression. They found that
among subjects who experienced no life stressors, 5-HTTLPR was not associated with
depressive symptoms. As the number of stressful life events reported by subjects increased,
however, subjects with at least one copy of the less transcriptionally active (low functioning)
5-HTTLPR short (S) allele reported significantly more depressive symptoms than subjects
with two copies of the high functioning 5-HTTLPR long (L) allele. To date, there have been
(at least) 37 follow-up studies, with some studies supporting the presence of an interaction
and others not.
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Two recent meta-analyses have assessed a subset of these studies and concluded that there is
no evidence supporting the presence of the interaction28,29. It is important to note, however,
that these meta-analyses have important limitations. First, in contrast to traditional genetic
association studies, there is marked variation in study design among studies examining this
interaction. Both meta-analyses were heavily weighted towards large studies in which
stressful events were not well assessed, while discounting studies with more comprehensive
assessments of stress that necessarily utilized smaller samples. Further, even the larger of the
two meta-analyses was able to include only 14 of the 38 published studies that examined the
relationship between 5-HTTLPR, stress and depression. The vast majority of the studies
excluded by the meta-analysis reported that the presence of the 5-HTTLPR S allele
increased the risk of depression under stress, suggesting that it is premature to draw
definitive conclusions about the presence or absence of this interaction from these metaanalyses30-49.
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The inconsistency among studies to date may be due in part to methodological limitations of
some of these studies50. First, most of the studies assessed stressful life events and
depressive symptoms retrospectively and concurrently. For some studies, subjects were
asked to recall stressors and putative depressive episodes that occurred many years before
the interview51,52. This is problematic because the induction of depressed mood
significantly increases the recall of stressful life events53. Further, individuals with a history
of depression experience more perceived life events than healthy individuals54. As a result,
many of the studies to date do not adequately disentangle the cause and effect relationship
between depression and reports of life stress. Additionally, most previous studies assessed a
set of life stressors that were highly variable in character and intensity. Combining
quantitatively and qualitatively disparate stressors may act to increase the “noise” of a study,
reducing the statistical power to detect interaction effects.
Some studies have attempted to avoid the problems of impaired recall and variable stressors
by focusing on specific populations that have experienced a substantial, uniform stressor
such as stroke or myocardial infarction39-48. However, because these “specific stressor”
studies assess subjects only after the onset of the stressor, they cannot determine whether the
depression was present before the onset of the stressor or whether the depression played a
role in precipitating the stressor. Although one could study this question prospectively, with
depression measured in the same subjects before and after the onset of a uniform stressor, it
is generally not possible to predict the occurrence of a stressor. Medical internship provides
a rare instance in which the onset of a major stressor can be predicted for a defined
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population. The present study seeks to identify the factors important in the development of
depression during medical internship and to utilize internship as a stress model to study
subjects before and after the onset of a major stressor and assess the moderating effect of 5HTTLPR on the development of depression.

Methods
Participants
1394 interns entering traditional and primary care internal medicine, general surgery,
pediatrics, obstetrics/gynecology, and psychiatry residency programs during the 2007-2008
and 2008-2009 academic years were sent an email two months prior to commencing
internship and invited to participate in the study. For 123 subjects, our email invitations
were returned as undeliverable and we were unable to obtain a valid email address. 58%
(740/1271) of the remaining invited subjects agreed to participate in the study. The
Institutional Review Board at Yale University and the participating hospitals approved the
study. Subjects were given $30 (2007-2008 cohort) or $40 (2008-2009 cohort) gift
certificates to participate in the study.
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Data Collection
All surveys were conducted through a secure online website designed to maintain
confidentiality, with subjects identified only by numbers. No links between the identification
number and the subjects' identities were maintained.
Depressive symptoms were measured using the depression module of the Patient Health
Questionnaire (PHQ-9)55. The PHQ-9 is a self-report component of the PRIME-MD
inventory designed to screen for depressive symptoms. For each of the 9 depressive
symptoms, interns indicated whether, during the previous 2 weeks, the symptom had
bothered them “not at all,” “several days,” “more than half the days,” or “nearly every day.”
Each item yields a score of 0 to 3, so that the PHQ-9 total score ranges from 0 to 27. PHQ
scores of 10 or greater, 15 or greater and 20 or greater correspond to moderate, moderately
severe and severe depression respectively56. A score of 10 or greater on the PHQ-9 has a
sensitivity of 93% and a specificity of 88% for the diagnosis of MDD56. Diagnostic validity
of the PHQ-9 is comparable to clinician-administered assessments55.
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Initial Assessment—Subjects completed a baseline survey 1-2 months prior to
commencing internship that asked about general demographic factors (age, sex, ethnicity,
marital status), medical education factors (American or foreign medical school, medical
specialty), personal factors (baseline PHQ-9 depressive symptoms, self-reported history of
depression) and the following psychological measures: 1) Neuroticism (NEO-Five Factor
Inventory57) 2) Resilience (Connor-Davidson Resilience Scale58) 3) Perceived Stress
(Perceived Stress Scale59) 4) Social Supports (Sarason Social Support Questionnaire60) 5)
Early Family Environment (Risky Families Questionnaire61) and 6) Cognitive Styles
(modified Sociotropy-Autonomy Scale62).
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Within-Internship Assessments—Participants were contacted via email at months 3, 6,
9 and 12 of their internship year and asked to complete the PHQ-9. They were also queried
regarding their rotation setting, perceived medical errors, work hours and sleep over the past
week and the occurrence of a series of non-internship life stress (serious illness, death or
serious illness in close family or friend, financial problems, end of serious relationship, and
becoming a victim of crime or domestic violence) during the past three months.
DNA Collection
Subjects choosing to take part in the study were given the option to submit a saliva sample
for DNA extraction. We used the Oragene salivary DNA self-collection kit63, which allows
for subjects to submit a salivary sample by mail without direct contact with study personnel.
Serotonin Transporter Genotyping
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The serotonin transporter 5-HTTLPR variant was genotyped using previously described
PCR conditions and primers64. An A→G single nucleotide polymorphism (SNP) has been
identified within the 5-HTTLPR repeat region (rs25531)65. Functional studies have shown
that promoter regions with the 16-repeat variant and the “G” allele (LG) were functionally
equivalent to the low functioning 14 repeat variant (S allele). To genotype the additional
SNP that occurs in the VNTR repeat region of the SLC6A4 promoter65, we used a restriction
enzyme assay described previously66.
Statistical Analysis
All analyses were performed using SPSS 16.0 (Chicago, IL). The point prevalence of
depressive symptoms and a positive screen for depression during internship were determined
through analysis of PHQ-9 depressive symptom scores at the 3, 6, 9 and 12-month
assessments. To investigate whether there was a significant change in depressive symptoms
during the internship year, we compared baseline PHQ-9 depressive symptoms and
depressive symptoms at the 3, 6, 9 and 12-month assessments through a series of paired ttests.
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Baseline Factors—The association between variables measured at baseline and the
development of depressive symptoms during internship was assessed through a two-step
process. Using Pearson correlations for continuous measures and chi-square analyses for
nominal measures, we identified baseline demographic variables that were associated with
the mean change in depressive symptoms from baseline to the quarterly assessments during
internship (PHQ-9(change) = mean PHQ-9 depressive symptoms(3-, 6-, 9- and 12-month
assessments) – PHQ-9 depressive symptoms(baseline)). Significant variables were
subsequently entered into a stepwise linear regression model to identify significant
predictors while accounting for collinearity among variables.
Within-Internship Factors—The association between variables measured through
recurring assessments during internship (within-internship variables) and change in
depressive symptoms were assessed through generalized estimating equation (GEE) analysis
to account for correlated repeated measures within subjects. Internship variables (work
hours, occurrence of medical errors, hours of sleep, non-internship stressful life events) were
Arch Gen Psychiatry. Author manuscript; available in PMC 2014 May 28.
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incorporated as predictor variables and associated baseline factors were used as covariates.
We utilized concurrently measured depressive symptoms as the outcome variable (i.e. 3month depressive symptoms was indexed to the 3-month within-internship variable, 6month depressive symptoms indexed to 6-month medical errors etc.).
Next, to gain insight into the direction of causality between associated within-internship
factors and depressive symptoms, we assessed whether depressive symptom score prior to
internship predicted increased levels of the associated within-internship variables at 3
months. For this analysis, we used a general linear model, with the associated withininternship measure as the dependent variable and baseline depressive symptom score as the
independent variable. Baseline factors associated with increased depressive symptoms were
included as covariates. Finally, for the variables for which baseline depressive symptom
score predicted increased levels of the associated within-internship variables at 3 months, we
tested whether the 3-month depressive symptom score was associated with the relevant
within-internship factor after controlling for baseline depressive symptoms. Thus, 3-month
depressive symptom scores were reintroduced into the general linear model as an
independent variable in the analysis.
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Serotonin Transporter Polymorphism—Because there are substantial racial/ethnic
differences in 5-HTTLPR allele frequencies (S allele frequency: Caucasian–0.44; African–
0.11; Chinese– 0.70)64, we performed separate analyses for individual racial/ethnic groups
to minimize the chance of false association due to the presence of population stratification67.
To explore the effects of 5-HTTLPR and stress on the emergence of depressive symptoms,
we performed a GEE analysis with the presence of a 5-HTTLPR low functioning allele (S or
LG) as the grouping variable and change in depressive symptoms as the outcome variable.
To gain insight into the specific factors that moderate a potential genotype effect on
depressive symptoms, we introduced the baseline and within-internship factors that had
significant main effects on this outcome measure in the previous analysis and the
corresponding genotype × factor interaction terms as predictor variables into the GEE
analysis.

Results
NIH-PA Author Manuscript

Individuals who chose to take part in the study were younger (27.9 years old vs. 28.4 years
old; p<0.001) and more likely to be female (54.4% vs. 52.5%; p<0.001) than individuals that
chose not to participate (Table 1) (Supplemental Tables 1-4). 88% (651 of 740) of subjects
completed at least one follow-up survey with a mean of 69% of subjects responding to each
of the four follow-up surveys.
Prevalence of Depressive Symptoms
The mean PHQ-9 depressive symptom score reported by subjects increased significantly
from baseline (mean±SD) (2.38±2.99) to 3 months (6.70±5.37; p<0.001), 6 months
(6.33±4.98; p<0.001), 9 months (6.48±4.98; p<0.001) and 12 months (6.26±5.10; p<0.001)
of internship. Using the criteria for major depression developed by Kroenke et al56
(PHQ>10) the percentage of subjects meeting this diagnosis increased from 3.9% at baseline
to 27.1%, 23.3%, 25.7% and 26.6% at the 3, 6, 9 and 12-month time points of internship,
Arch Gen Psychiatry. Author manuscript; available in PMC 2014 May 28.
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respectively (Figure 1). 41.8% of subjects met criteria for major depression at one or more
quarterly assessments. On sensitivity analysis, assuming that all nonresponders did not
experience a depressive episode during internship, the prevalence of a depressive episode
during internship would be 19.5% (272/1394). The percentage of subjects meeting criteria
for moderately severe depression (PHQ>15) increased from 0.7% at baseline to 6.6%, 6.2%,
7.8% and 7.6% at the 3, 6, 9 and 12-month time points of internship, respectively. Similarly,
the percentage of subjects meeting criteria for severe depression (PHQ>20) increased from
0% at baseline to 2.3%, 1.6%, 1.8% and 0.8% at the 3, 6, 9 and 12-month time points of
internship, respectively.
To determine whether the increase in overall PHQ-9 score was due to an increase in all
depressive symptoms or only a subset, we assessed the change from baseline to mean
internship level individually for each of the PHQ-9 symptoms. Subjects reported a
significant increase (p<0.001) for all nine items). The increase in mean symptom score
ranged from 70% (difficulty sleeping) to 370% (thoughts of death).
Baseline Factors

NIH-PA Author Manuscript

Among 15 baseline variables tested, nine were significantly correlated with a change in
depressive symptoms from the baseline assessment to the mean of the four internship
assessments (Female sex: r=0.147, p<0.001; European-American ethnicity: r=0.084,
p=0.036; Personal history of depression: r=0.206, p<0.001; Lower baseline depressive
symptoms: r=0.126, p=0.002; U.S medical education: r=0.115, p=0.004; Higher
neuroticism: r=0.115, p <0.001; Difficult early family environment: r=0.108, p<0.001;
Higher perceived stress: r=0.094, p=0.020; Higher sociotropy: r=0.116, p=0.004). When
these nine variables were entered into the stepwise linear regression to account for
collinearity between variables, six variables remained significant (Neuroticism: β=0.24,
p<0.001; Personal history of depression: β=0.17, p<0.001; Lower baseline depressive
symptoms: β=0.38, p<0.001; Female sex: β=0.08, p=0.031; U.S. medical education: β=0.10,
p=0.005; Difficult early family environment: β=0.08, p=0.035).
Within-Internship Factors
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We used a GEE analysis to assess factors during internship that were associated with a
change in depressive symptoms while controlling for repeated measurements. Three withininternship variables were associated with an increase in depressive symptoms (Work hours:
Wald Chi Square(99)=2.8×1011, p<0.001; Reported medical errors: Wald Chi
Square(1)=16.2, p<0.001); Non-internship stressful life events: Wald Chi Square(5)=71.6, p
<0.001;. There were no significant gender interactions for any of the associated baseline or
within-internship factors (data not shown).
To gain insight into the direction of the association of within-internship factors and
depression, we assessed whether baseline depressive symptoms predicted an increased level
of the within-internship factor at the 3-month internship assessment. Baseline depressive
symptom score predicted reported medical errors at 3 months (F(21)=2.201 p=0.002), but
not work hours (F(21)=1.116 p>0.05) or non-internship stressful life events (F(21) = 1.029
p>0.05) at 3 months. For the reported medical errors analysis, re-introduction of the 3-month
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months even in the presence of baseline depressive symptoms (F(27)=1.676 p=0.004).
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Serotonin Transporter Genotype
A total of 409/652 (63%) of eligible subjects provided saliva samples. There were no
significant differences on sex, age or ethnicity between subjects that provided a sample and
those that did not. For both major racial/ethnic groups in our sample (European-American
and Asian), allele frequencies were consistent with previous reports and Hardy-Weinberg
Equilibrium (data not shown). Among European-Americans, subjects with at least one low
functioning 5-HTTLPR (S or LG) allele reported a significantly greater increase in
depressive symptoms than subjects with two high functioning 5-HTTLPR (LA) alleles Wald
Chi Square(1)=8.2, p=0.004 (Figure 2). The percentage of European-American subjects with
at least one low functioning 5-HTTLPR allele who met criteria for depression increased
from 2.4% before internship to 42.5% at its highest during internship, while the percentage
of European-American subjects with two high functioning 5-HTTLPR alleles who met
criteria for depression increased from 5.1% before internship to 36.2% at its highest during
internship.
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To identify variables that moderate the relationship between 5-HTTLPR and depressive
symptoms, we introduced the main effect and interaction terms consisting of genotype and
each of the baseline and within-internship variables that were significantly associated with
an increase in depressive symptoms into the 5-HTTLPR GEE analysis. Among baseline
variable, there was a significant interaction of 5-HTTLPR with neuroticism (Wald Chi
Square(19)=30.6 p=0.045) but the interactions of 5-HTTLPR with the other five baseline
variables were not significant. Among within-internship variables, there was a significant
interaction of 5-HTTLPR with work hours (Wald Chi Square(61)=5757.3, p<0.001) but the
interactions of 5-HTTLPR with non-internship stressful life events and reported medical
errors were not significant. Among Asian subjects, there was no difference in the change in
depressive symptoms between genotype groups (t=1.06; p>0.05).

Comment
NIH-PA Author Manuscript

In this study, we found that the rate of depression increased dramatically during the
internship year, from 3.9% of subjects meeting PHQ-9 criteria for depression before
internship to an average of 25.3% of subjects meeting criteria at quarterly assessments
during the internship year. The majority of subjects who met criteria for depression were
classified as moderately depressed, with few subjects meeting PHQ-9 criteria for moderately
severe or severe depression. Because the development of major depression has been linked
to higher risk for future depressive episodes and greater long-term morbidity risk68,69, future
studies should examine how the rate of depression changes as training physicians progress
through their careers beyond internship and the possible effects of depression on the general
health of physicians.
Beyond assessing depression prevalence, we also identified a series of factors associated
with the development of depressive symptoms during internship. The baseline factors that
were associated with the development of depression in this study include some that have
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been implicated in prior residency studies (female sex, difficult early family environment,
neuroticism and a prior history of depression) and other factors not previously identified
(U.S. medical education and lower baseline depressive symptoms). It is also interesting to
note that a number of factors, such as medical specialty and age, were not associated with
the development of depression. With effective interventions to help prevent the onset of
depression now available, the predictive factors identified here could allow at-risk interns to
take steps before the onset of symptoms to lower their chances of developing depression70.
As with baseline factors, we identified within-internship factors that were previously
implicated, as well as novel factors associated with the development of depression. Our
finding that medical errors are associated with depression supports the findings of two recent
studies71,72. Here we extend the association identified in prior studies by demonstrating that
depressive symptoms present before internship predicted reported errors during internship,
indicating that depression results in increased medical errors. Controlling for the baseline
level of depressive symptoms, a strong correlation between errors and depression persisted,
indicating that errors may also cause depression and that the relationship between depression
and reported medical errors is bi-directional.

NIH-PA Author Manuscript

In addition to building on previous work exploring the relationship between medical errors
and depression, this is the first study to demonstrate a direct association between the number
of hours worked and risk of depression in medical interns. In contrast to our finding with
medical errors, we found no evidence that depressive symptom score before internship
predicted work hours during internship. These findings suggest that the association between
work hours and depression during internship is due to increased work hours leading to
increased depressive symptoms during internship. Future studies could explore whether
systemic changes designed to improve patient safety, such as additional safeguards against
medical errors and further resident work hour restrictions, reduce the development of
depression among interns.
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There are a number of limitations to our findings related to depressive symptoms and
internship. First, our finding that the association between depressive symptoms and reported
medical errors persisted when controlling for pre-existing depressive symptoms does not
definitively prove that errors led to depression. It is possible that some third factor
differentially promoted depression in a subset of the sample and also led to an increase in
the reported within internship factor in that group of residents. Though no variable that we
measured (gender, age, specialty or institution) appeared to account for this effect, it is
possible that an unmeasured variable could have caused the effect.
Second, only 58% of invited individuals chose to participate in the study. Although there
were only modest differences in age and gender between those who chose to take part in the
study and those who did not, our results should be extrapolated with caution.
Third, although multiple studies have demonstrated the validity, sensitivity and specificity of
the PHQ-9 inventory, it is important to note that we assessed depression through a selfreport inventory rather than a diagnostic interview.
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Fourth, we assessed medical errors through self-report rather than through objective
measurement leading to the possibility that we did not accurately capture the occurrence of
medical errors. For instance, the established tendency of depressed individuals towards
enhanced memory of emotionally negative events may have resulted in depressed residents
recalling more errors rather than actually committing more errors26. Previous studies
however, have demonstrated that resident self-report of errors can act as a reasonable proxy
for errors assessed through chart review and that self-report was actually more effective in
detecting preventable errors73,74.
Finally, our study was restricted to interns and thus our results may not hold for advanced
residents or physicians who have completed their training. In addition, although we did not
find significant differences in results among hospitals or specialties, the interns and
programs included here may not be representative of the country in general.
Serotonin Transporter, Stress and Depressive Symptoms
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In addition to identifying factors associated with the development of depression during
internship, we also used internship as a model to explore the relationship between a
serotonin transporter promoter polymorphism and stress in the development of depression.
We found evidence that this variant moderates the response to stress in European-American
subjects, with subjects carrying at least one low functioning 5-HTTLPR allele reporting a
43% greater increase in depressive symptoms than subjects with two low functioning alleles.
Consistent with an earlier study exploring the 5-HTTLPR × stress interaction in the context
of personality traits, we found that the relationship between 5-HTTLPR and the
development of depressive symptoms under stress was moderated by neuroticism34. Further,
in exploring the type of stress for which 5-HTTLPR affects sensitivity, we found evidence
supporting an interaction of 5-HTTLPR with work hours, but not with medical errors or
stressful life events. This finding supports the results of a prior study in which the 5HTTLPR × stress interaction effect on depressive symptoms was the result of increased
sensitivity to common, mild stressors among individuals carrying the low functioning allele,
rather than an increased sensitivity to rare and severe life events33. The relationship between
5-HTTLPR, stress and depression has not been well studied in Asian populations. In our
sample, there was no evidence that 5-HTTLPR genotype influenced the change in
depression score among subjects of Asian ethnicity.
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The results of our study support the original study that demonstrated a relationship between
5-HTTLPR, stress and depression risk27 but conflict with the results of some other studies
and two recent meta-analyses. It is possible that no actual interaction exists and the results of
our study, along with the other studies reporting a significant interaction, are false positives.
However, because the approaches used in studies exploring the interaction vary
substantially, an alternate explanation for our findings is that a true, but modest gene ×
environment interaction effect exists, but that certain study design features are necessary to
detect the effect75. Our study illustrates a number of features that may be important to
maximize the power to detect gene × environment interaction effects. First, we used a
stressor that has a substantial direct effect on depression. This is in contrast to many of the
negative studies exploring this interaction that assessed a set of life stressors that were

Arch Gen Psychiatry. Author manuscript; available in PMC 2014 May 28.

Sen et al.

Page 11

NIH-PA Author Manuscript

highly variable in character and intensity. Second, by utilizing a prospective design, we
minimized the biases inherent in the retrospective and concurrent assessment of stress and
depressive symptoms present in other studies.
It is interesting to note that eight of the ten previous studies that avoided the problems of
impaired recall and variable stressors by utilizing a “specific stressor” approach have
reported an association between the 5-HTTLPR S allele and increased depression under
stress39-48. Here we extend the results of that “specific stressor” group of studies by
assessing the same subjects, before and after the onset of the stressor. This allowed us to
avoid the confounding attributable to differences between subjects that are inherent in casecontrol studies and demonstrate that the association between genotype and depressive
symptoms was not present before the onset of the stressor. Last, we maximized the genetic
information obtained from the locus of interest by genotyping the functional SNP within the
5-HTTLPR locus and functionally classifying the low functioning LG allele with the low
functioning S allele. The functional misclassification of alleles in some previous studies may
also have reduced the power to detect interaction effects.
Overall Significance
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In summary, we conducted the largest prospective study to date of depression during
medical internship. We identified a high level of depressive symptoms among interns and a
series of baseline and within-internship factors that associated with increased depressive
symptoms in this population. Subsequent studies that more fully explore the consequences
of depression among interns both on patients and the physicians-in-training themselves are
needed. In this study we also utilized internship to model the relationship between 5HTTLPR, stress and depression and found that the 5-HTTLPR low functioning allele was
associated with a significantly greater increase in depressive symptoms under stress. Our
study highlights the striking variation in experimental design among studies of this
interaction and the impact on the findings of these different designs. In the future, metaanalyses exploring the relationship between 5-HTTLPR, stress and depression should
account for this variation in study design and systematically assess whether heterogeneity of
study design predicts with the estimated overall effect.
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Figure 1.

This figure demonstrates the proportion of interns who meet PHQ criteria for depression54
prior to internship and at 3-month intervals through intern year.
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Figure 2.

This figure displays PHQ depression scores for Caucasian subjects stratified by the presence
of at least one copy of a 5-HTTLPR low functioning allele. The left side of the figure shows
the PHQ depression score prior to the stress of internship. The right side of the figure shows
the mean PHQ depression score during internship.
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Table 1

Sample Demographic Characteristics
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This table provides Beta and SEM values from a stepwise linear regression for baseline factors and Wald Chi
Square values from a generalized estimating equation (GEE) analysis for within-internship factors.
Variable
Sex

Age

No (%)
Male

337 (45.6)

Female

403 (54.4)

≤25

101 (13.6)

26-30

533 (72.1)

31-35

84 (11.3)

>35
Specialty

358 (48.5)

General Surgery

98 (13.3)

OB/Gyn

42 (5.7)
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Pediatrics

94 (12.7)

Psychiatry

63 (8.5)

Emergency Medicine

47 (6.3)

Med/Peds

19 (2.6)

Family Medicine
Relationship Status

22 (3.0)

Internal Medicine

Single
Married
Divorced

19 (2.6)
79 (64.7)
248 (33.5)
13 (1.7)
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Table 2

Predictors of Increased Depressive Symptoms
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Baseline Factors
Factor

Beta

SEM

P value

Neuroticism

0.24

0.021

<0.001

Personal History of Depression

0.17

0.024

<0.001

Baseline Depressive Symptoms

-0.38

0.064

<0.001

Female Sex

0.08

0.311

0.031

US Medical Graduate

0.10

0.412

0.005

Difficult Early Family Environment

0.08

0.016

0.035

Within-Internship Factors
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Factor

Wald Chi Square (df)

P value

Mean Work Hours

2.8 × 10-11 (99)

<0.001

Medical Errors

16.2 (1)

<0.001

Stressful Life Events

71.6 (1)

<0.001
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Table 3
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Other

13
25
19

Low/Low

63

Low/Low

High/Low

14

High/Low

High/High

7

High/High

141
69

High/Low
Low/Low

Asian

58

High/High

European-American

N

5-HTTLPR functional genotype

Ethnicity

6.16

3.15

5.11

3.45

2.77

6.4

4.95

4.69

3.33

Mean

1.21

0.75

1.23

0.46

0.93

1.75

0.54

0.35

0.35

SEM

-

-

0.004

p value
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